Company Reports Q4 Revenue of $1.97B, Below Expectations
Reports Q4 revenue $1.97B, consensus $2.02B. "Despite a challenging operating environment for the chemical industry and continued weakness in consumer discretionary end markets, our team delivered a year that demonstrates the strength of our portfolio's ability to generate cash," said Mark Costa, Board Chair and CEO. "In 2025, we generated operating cash flow approaching $1 billion, a clear validation of our disciplined approach to cost and working capital management. Our commercial teams showed excellence in defending the value of our products, and we accelerated our structural cost reductions throughout the year to protect margins and preserve competitiveness. We continued to prioritize stockholder returns and raised the dividend for the 16th consecutive year. In total, we returned approximately $500 million through dividends and share repurchases. We also advanced our strategic growth initiatives, including achieving our Kingsport methanolysis operational goals, producing greater than 2.5 times the recycled content versus 2024 and delivering approximately $60 million of incremental earnings. Looking ahead, we enter 2026 with a diverse portfolio, strong cash-generation capability, and a winning team that is well positioned to drive earnings growth, improve our cost structure, and capture recovery-driven upside when market conditions improve."
Get Free Real-Time Notifications for Any Stock
Analyst Views on EMN
About EMN
About the author
Eastman Chemical Set to Report Q4 Earnings
- Earnings Announcement Date: Eastman Chemical (EMN) is set to release its Q4 earnings on January 29th after market close, with a consensus EPS estimate of $0.72, reflecting a significant year-over-year decline of 61.5%, indicating substantial pressure on profitability.
- Revenue Expectations Decline: The anticipated revenue for Q4 is $2.02 billion, down 10.2% year-over-year, which highlights the negative impact of weak market demand on the company's performance and may lead to decreased investor confidence.
- Historical Performance Review: Over the past two years, Eastman has beaten EPS estimates 75% of the time but only 50% for revenue, indicating volatility in earnings that could affect future investment decisions.
- Revised Expectations: In the last three months, there have been no upward revisions to EPS estimates, with 14 downward adjustments, and similarly, revenue estimates saw no upward revisions and 11 downward adjustments, reflecting a weakening market outlook for the company.
Eastman Chemical Q4 Revenue Misses Estimates, Shares Drop
- Revenue Decline: Eastman Chemical reported fourth-quarter revenue of $1.97 billion, down from the previous year and below analysts' expectations of $2.02 billion, resulting in a 2.2% drop in after-hours trading due to lower volumes across multiple end markets.
- Earnings Performance: Although adjusted earnings per share were $0.75, exceeding the consensus estimate of $0.72, net income was still impacted by overall revenue decline, highlighting the challenges the company faces in the current economic environment.
- Market Pressures: Sales fell across all major segments, particularly in chemical intermediates and fibers, primarily due to customer inventory destocking and competitive pressures in global commodity markets, exacerbating the decline in performance.
- Future Outlook: Eastman anticipates earnings improvement in 2026 driven by deeper cost reductions and higher utilization rates, although the company refrained from providing a full-year adjusted earnings forecast due to macroeconomic uncertainties.
